HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danièle Demarquay Selected Research

BIM 46174

9/2006Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danièle Demarquay Research Topics

Disease

2Neoplasms (Cancer)
09/2006 - 07/2004
1Poisoning
07/2004

Drug/Important Bio-Agent (IBA)

1BIM 46174IBA
09/2006
1Cyclic AMP (AMP, Cyclic)IBA
09/2006
1Topoisomerase InhibitorsIBA
09/2006
1Hormones (Hormone)IBA
09/2006
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2006
1Neurotensin Receptors (Neurotensin Receptor)IBA
09/2006
1Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
09/2006
1Frizzled ReceptorsIBA
09/2006
1Farnesyltranstransferase (Farnesyltransferase)IBA
09/2006
1CalciumIBA
09/2006
1Carrier Proteins (Binding Protein)IBA
09/2006
1Cisplatin (Platino)FDA LinkGeneric
09/2006
1Pharmaceutical PreparationsIBA
09/2006
1GuanineIBA
09/2006
1AndrogensIBA
07/2004
1trioctyl phosphine oxide (TOPO)IBA
07/2004
1Proteins (Proteins, Gene)FDA Link
07/2004
1homocamptothecinIBA
07/2004
1DNA (Deoxyribonucleic Acid)IBA
07/2004